Skip to content

Inhibition of liver cystogene

Inhibition of liver cystogene - TVP for PKLD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028060
Enrollment
150
Registered
2017-10-01
Start date
2017-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic kidney disease

Interventions

None listed

Sponsors

Toranomon Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Kidney volume>= 750ml rate of Kidney volume increase >=5%/year TLV>=2000cm^3

Exclusion criteria

Exclusion criteria: eGFR<15 Hypernatremia Chronic liver injury Patients who do not feel thirsty or have difficulty in ingesting water Pregnant woman do not obtain consent Doctor judged inappropriate

Design outcomes

Primary

MeasureTime frame
Changes in TLV

Secondary

MeasureTime frame
Changes in TKV, eGFR, and urinary osmorality

Countries

Japan

Contacts

Public ContactJunichi Hoshino

Toranomon Hospital Nephrology Center

hoshino-ind@umin.ac.jp03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026